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NADPH oxidases (NOX) mediate redox signaling by generating superoxide and/or hydrogen peroxide,
which are involved in biosynthetic pathways, e.g. thyroid hormone generation, dityrosine crosslinking, as
well as bacterial killing. Data investigating the role of NOX enzymes in cutaneous wound repair is limited
and speciﬁcally their function in skin myoﬁbroblast expression is unknown. The isoform NOX4 was re-
cently shown to be a pre-requisite for the differentiation of cardiac and pulmonary myoﬁbroblasts.
In this study we investigate the role of NOX4 in wound repair using a wound model in NOX4
knockout mice (n¼16) and wildtype mice (n¼16). Wounds were photographed daily until complete
wound closure. Mice were sacriﬁced at day 3, 7, 14; wound tissue was harvested.
NOX4-deﬁcient mice healed signiﬁcantly slower (22 days, SD¼1.9) than wild-type mice (17 days,
SD¼1.4, po0.005). However, there was no difference in myoﬁbroblast expression. Strong dityrosine
formation was observed, but was signiﬁcantly weaker in NOX4-/- mice (po0.05). NOX2, HIF1α and CD31
expression was signiﬁcantly weaker in NOX4-/- mice (po0.05).
In this study we show for the ﬁrst time that NOX4 plays a role in cutaneous wound repair. Our data
suggests that NOX4 mediates HIF1α expression and neoangiogenesis during wound repair. NOX4 dele-
tion led to a decreased expression of NOX2, implying a role of NOX4 in phagocytic cell recruitment. NOX4
was required for effective wound contraction but not myoﬁbroblast expression. We suggest that myo-
ﬁbroblast contraction in NOX4-deﬁcient mice is less effective in contracting the wound because of in-
sufﬁcient dityrosine-crosslinking of the ECM, providing the ﬁrst indication for a physiological function of
dityrosine crosslinking in higher animals.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Wound repair is a complex, dynamic and interactive process
that involves a great variety of cells, soluble mediators and ex-
tracellular matrix components. In order to guarantee rapid and
effective wound closure, wound contraction is of primordial im-
portance. When the wound contracts, the uninjured skin sur-
rounding the wound is pulled into the defect, signiﬁcantly redu-
cing the amount of time and tissue needed to reestablish the in-
tegrity of the skin barrier after injury. The exact mechanisms un-
derlying wound contraction are not yet fully understood. Cellular
contraction of specialized contractile ﬁbroblasts – myoﬁbroblasts –
constitutes one of the key components of effective woundInc. This is an open access article ucontraction [1,2]. Fibroblast-to-myoﬁbroblast differentiation oc-
curs primarily in response to growth factors (mainly transforming
growth factor beta 1 (TGFβ1)) and mechanical stress. Myoﬁbro-
blast are characterized by the expression of α-smooth muscle actin
(αSMA) in stress ﬁbers, which is considered to be the molecular
basis for their high contractility [1–3].
In recent years it has become increasingly clear that redox
signaling is involved in a myriad of physiological cell functions
including differentiation, proliferation, apoptosis and migration
[4–6]. NOX enzymes are membrane-bound complexes that trans-
port electrons across biological membranes to reduce oxygen to
superoxide-radical and play a key role in mediating redox signal-
ing [5]. Seven isoforms of NOX enzymes have been described:
NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1, and DUOX2. Despite
their similar structure, they differ in function and mechanism of
activation. During wound repair, they could play important roles in
key elements such as coagulation, inﬂammation, ﬁbroplasia,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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NOX2 during wound repair is long known in microbial killing as it
guarantees the production of large amounts of reactive oxygen
species (ROS) by immune cells, which is of great importance for
effective host defense [8–11]. In fact, patients with chronic gran-
ulomatous disease, a rare congenital abnormality of the NOX2
system, show impaired wound repair and are more prone to
wound infection [12]. Our knowledge concerning the role of NOX-
mediated redox signaling in wound repair, especially concerning
wound contraction, is still limited and relies mainly on studies
conducted in other ﬁelds than skin wound repair.
Recent literature shows that TGFβ1 induces hydrogen peroxide
production in human ﬁbroblasts [13]. In fact, NOX4 has been re-
ported to mediate TGFβ1-induced myoﬁbroblast differentiation of
cardiac [14] and pulmonary ﬁbroblasts [15] as well as the pro-
liferation of pulmonary smooth muscle cells [16]. Carnesecchi et al
investigated the role of NOX4 in ﬁbroblast-to-myoﬁbroblast dif-
ferentiation during bleomycin-induced pulmonary ﬁbrosis, the
accumulation of myoﬁbroblasts being a hallmark in advanced and
progressive pulmonary ﬁbrosis. They showed that NOX4 was a
prerequisite for myoﬁbroblast differentiation [17]. The accumula-
tion of myoﬁbroblasts during lung ﬁbrosis is mainly driven by
TGFβ1 signaling [18,19], in line with what has been observed in
cutaneous wound repair studies [20].
The extracellular matrix (ECM) plays a primordial role in
wound repair, not only for myoﬁbroblast differentiation but also
for wound contraction itself. The crosslinking of ECM proteins is
crucial for the development of a mechanically resistant granula-
tion tissue. Dimerization of the phenolic amino acid L-tyrosine has
been suggested as a possible mechanism of crosslinking ECM
proteins. Both collagen and elastin have been shown to undergo
dityrosine crosslinking when H2O2 is added exogenously [21,22].
In culture, it has been observed that TGFβ1-activated ﬁbroblasts
release ROS in the extracellular space in a NOX-mediated manner
[23]. Larios et al reported that H2O2 generated by TGFβ1-activated
ﬁbroblasts are capable of mediating dimerization of L-tyrosine in
the ECM [24]. A physiological function for NOX/ROS-dependent
cross-linking of dityrosine residues in the ECM has so far only be
demonstrated in primitive organisms: stabilization of cutaneous
tissue in Caenorhabditis elegans [25]; hardening of the fertilization
envelope in sea urchin eggs [26]; and stabilization of drosophila
wings [27]. We hypothesize that NOX4 plays a role in the devel-
opment of the granulation tissue during wound repair by med-
iating ROS-induced crosslinking of tyrosine residues in the ECM.
NOX4 may also play a role in other processes of wound repair,
possibly during angiogenesis as it was previously reported that
growth of blood vessels into sponges is abolished in NOX4
knockout mice [28]. Hypoxia is arguably the most important
trigger for angiogenesis during wound repair. NOX4 could play a
key role in cell response to hypoxia. Pulmonary artery smooth
muscle cells cultured under hypoxic conditions showed increased
expression of NOX4 [4,29] and their proliferation was NOX4-de-
pended [30]. There is increasing evidence that the stabilization of
hypoxia-inducible factor (HIF) can also be directly induced by ROS
[31,32]. In fact, there appears to be a positive feed-forward loop
involving NOX4 and HIF1α: ROS generated by NOX4 activate
HIF1α [33] and HIF1α activates the expression of NOX4 [34]. The
notion that redox signaling plays an important role in angiogen-
esis is supported by evidence suggesting that a large number of
antioxidants limit angiogenesis [35–37].
In this study we aimed to understand 1) whether NOX4 plays a
role in cutaneous wound repair, 2) whether NOX4 is necessary for
effective contraction studying myoﬁbroblast expression, collagen
deposition and dityrosine crosslinking and 3) whether NOX4 plays
a role in HIF1α expression and angiogenesis during wound repair.2. Material and methods
2.1. Animal wound model
In this study, 16 wild type mice (C57BL/6J) and 16 NOX4
knockout mice (B6/129S9-NOX4) were used. We created circular
full thickness wounds of 1.5 cm diameter (1.8 cm2) on the back of
NOX4-deﬁcient knockout mice and of wild type mice, using a
circular template. All animal experiments were approved by the
local veterinary authority (“Direction générale de la santé de
Genève”, authorization number G65/3878).
2.2. Wound repair assessment
Wound size and aspect was documented immediately after
wounding and on day 3, 7, 10, 14, 17 and 21. Wounds that were
close to complete wound closure at any of these time points were
photographed daily from there on in order to determine the day of
complete wound closure. Wounds were photographed at a con-
stant distance with a ruler next to the wound for scaling. The
wound surface was calculated on photos using a computer-as-
sisted image analysis system (Image J).
At complete wound closure (i.e., full epithelialization), the
surface of hairless skin of the scar was measured and considered to
correspond to the area of the wound healed by epithelialization.
The surface of the wound healed by contraction was then esti-
mated by subtraction of the epithelialized surface from the wound
surface measured at day 0.
2.3. Histology and immunohistochemistry
Mice were sacriﬁced at day 3, 7 and 14 (n¼2 per time point
and per group) and the entire wound with the souring uninjured
skin was removed. The tissue was ﬁxed in 4% buffered
formaldehyde.
4 μm thick tissue sections were analyzed by im-
munohistochemistry using with the Ventana Discovery automated
staining system (Ventana Medical Systems, Tucson, AZ, USA).
Ventana reagents were used for the entire procedure.
For αSMA (anti-alpha-smooth muscle actin, Dako, #M0851,
70mg/ml) and DT (anti dityrosine, JaICA, MDT-020P, 100ug/ml)
mouse monoclonal antibodies, no antigen retrieval pre-treatment
was required. After automatic deparafﬁnization, slides were in-
cubated 30 minutes at 37 °C with primary antibodies diluted at
1/300 and 1/400 respectively for αSMA and DT. Then secondary
antibodies were applied at dilution 1/250 (anti-mouse Ig-
G1þ IgG2aþ IgG3, abcam, ab133469, 2.03 mg/ml). Detection of
secondary antibodies was carried out using the rabbit OmniMap
kit (Ventana Medical Systems), based on conversion of diamino-
benzidine to a dye with multimeric horseradish peroxidase (HRP).
For HIF1α (Novusbio, NB100-479, 1 mg/ml), antigen retrieval
was performed by heating slides 36 mns in standard CC2 EDTA
solution pH 8.4, dilution 1/400, detection Rabbit-OmniM detection
kit.
For CD31 (Abcam, ab28364), antigen retrieval was performed
by heating slides 52 min in standard CC1 citrate solution pH 6.0,
dilution 1/50, detection Rabbit-OmniM detection kit.
MPO staining was performed using a rabbit polyclonal antibody
(Dako,#A0398, 3.2 g/L). Slides were incubated 12 min in CC1 buf-
fer for antigen retrieval and primary antibody was incubated
30 min at 37 °C at dilution 1/1000. As a negative control, spinal
cord tissue of wildtype mice was used. As a positive control, we
used spinal cord tissue from an amyotrophic lateral sclerosis
mouse model which is known to have activated microglia that
express MPO [38].
NOX2 staining was performed using a mouse monoclonal
D. Lévigne et al. / Free Radical Biology and Medicine 96 (2016) 374–384376antibody (Santa Cruz, #sc-130548, 200 μg/ml). Slides were in-
cubated 36 min in CC1 buffer for antigen retrieval. First the pri-
mary antibody was incubated 30 min at 37 °C at dilution 1/100
and then a secondary antibody was applied at dilution 1/250 (anti-
mouse IgG1þ IgG2aþ IgG3, abcam, ab133469, 2.03 mg/ml).
Detection was carried out using the rabbit OmniMap kit
(Ventana Medical Systems), based on conversion of diamino-
benzidine to a dye with multimeric horseradish peroxidase (HRP).
NOX2 antibody control staining was performed using the same
antibody in immunoﬂuorescence on cell cultures of mouse bone-
marrow-derived dendritic cells ﬁxed in PFA 4% at a 1:100 dilution
of either wildtype or NOX2-/- mice (data kindly provided by Dr
Tamara Seredenina, Department of Pathology and Immunology,
University of Geneva).
Standard Masson’s trichrome staining was used to quantify
collagen expression.
2.4. Image analysis
Sections were scanned with a Mirax Wideﬁeld scanner
(brightﬁeld detector: Marlin F-146C IRF Medical). Pictures were
then processed using Deﬁniens Tissue Studio software (Deﬁniens
AG, Munich, Germany). Regions of interest (ROIs) were deﬁned in
the granulation tissue and in the epithelium. To evaluate α-SMA
expression, vessels were manually excluded from the image to
exclude pericytes. Results were given as % of ROI area stained.
2.5. Statistical methods
All values are expressed as mean7standard deviation (SD).
Data was analyzed with Prism6 software (GraphPad Software Inc.,
La Jolla, USA). Statistical analysis consisted in a comparison of data
from wild type versus NOX4-deﬁcient mice, using two-tailedFig. 1. A) Wound aspect in wildtype and NOX4-/- mice: Wounds in both groups heale
wound closure, scale bar¼1 cm. B) Percentage of mice with open wounds over time: wh
24 days in the NOX4-/- group, Mantel-cox test comparing the two curves showed a p val
signiﬁcantly slower compared to wildtype mice (white par bar), whiskers indicate minStudent t-tests for unpaired comparisons between groups. Differ-
ences were considered signiﬁcant at po0.05. In cases of multiple
comparisons, a post hoc correction with the Bonferroni procedure
was performed. The Mantel-cox test was used for comparing the
difference between the control and NOX4-deﬁcient group in per-
centage of wounds closed at different time points.3. Results
3.1. Macroscopic analysis
We observed a signiﬁcant delay in wound closure in NOX4-
deﬁcient mice compared to the control group. The macroscopic
wound aspect showed no obvious difference with regards to
granulation tissue formation or ﬁbrin deposition (see Fig. 1a).
While it took 18 days until 90% of the wounds were closed in the
control group, it took 24 days in the NOX4-/- group (see Fig. 1b).
Wounds in the control group took on average 17 days until com-
plete wound closure (SD¼1.4) compared to 22 days in the NOX4-/-
group (SD¼1.9, po0.005, see Fig. 1c).
When looking at the fraction of the wound area closed by re-
epithelialization (hairless skin at the time of complete wound
closure), we observed that wounds healed almost exclusively by
contraction, as expected for this kind of wound repair mouse
model (6.172.3% and 6.772.4% of the surface healed by re-epi-
thelialization in wildtype and NOX4-/- mice respectively). The
difference in the ratio between epithelialization and contraction
between the two groups was not statistically signiﬁcant.
3.2. Myoﬁbroblast expression
Staining for αSMA revealed no statistically signiﬁcantd predominantly through contraction. NOX4-/- mice showed a signiﬁcant delay in
ile it took 18 days until 90% of the wounds were closed in the control group, it took
ue of o0.005. C) Time to complete wound closure: NOX4 -/- mice (gray bar) healed
and max values, n¼10 per group, po0.005.
Fig. 2. Myoﬁbroblast expression. Immunohistochemistry showing αSMA expression in the granulation tissue at day 3, 7 and 14 after wound inﬂiction in wildtype (left
column) and NOX4-/- mice (middle column). E¼epithelium; G¼granulation tissue, V¼vessel. A strong increase in expression of αSMA was observed at day 7 with a further
increase at day 14. Computer-assisted quantiﬁcation (right column) showed no signiﬁcant difference between wildtype and NOX4-/- mice in αSMA expression in the
granulation tissue. Values are expressed as % area of the region of interest stained by immunohistochemistry and as mean7SD.
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weak expression of αSMA at day 3 (0.570.47% vs 0.570.2% of ROI
stained respectively) and a strongly increased expression at day 7
(13.271.6% vs 12.074.3%), which was again increased at day 14
(20.071.8% vs 18.374.0%) (see Fig. 2).
3.3. Collagen deposition
Masson’s trichrome staining showed less methyl blue staining
(collagen ﬁbers) in the granulation tissue of NOX4-/- mice com-
pared to the wildtype group. A tendency toward a decreasedFig. 3. Masson’s trichrome staining. Pictures of wound edges at day 3, 7 and 14 after
E¼epithelium; G¼granulation tissue. Computer-assisted quantiﬁcation of methyl blue in
group compared to control mice. Values are expressed as % area of the region of intereexpression was found at day 3 and 7, a signiﬁcant difference was
seen at day 14 (65.375.4 % of ROI stained in control animals vs
19.9716.5% in NOX4-/- animals; po0.05) (see Fig. 3).
3.4. Dityrosine formation
Dityrosine staining revealed a strong expression in wildtype
mice in the granulation tissue at day 3 (23.676.6% of ROI stained)
while NOX4-deﬁcient mice showed a signiﬁcantly weaker ex-
pression (4.171.3% of ROI stained, po0.05). At day 7, dityrosine
expression increased in wildtype and NOX4-/- mice (34.873.6% vswound inﬂiction in wildtype (left column) and NOX4-/- mice (middle column).
the granulation tissue showed signiﬁcantly lower values at day 14 in the NOX4 -/-
st stained by methyl blue and as mean7SD; *po0.05.
Fig. 4. Dityrosine formation. Immunohistochemistry showing dityrosine formation at day 3, 7 and 14 after wound inﬂiction in wildtype (left column) and NOX4-/- mice
(middle column). E¼epithelium; G¼granulation tissue. Dityrosine formation appeared weaker in the NOX4-/- group at all time points in the granulation tissue. No dif-
ference was observed in the epithelium at the wound edge. Computer-assisted quantiﬁcation (right column) showed a signiﬁcant impair of dityrosine formation in NOX4-/-
mice in the granulation tissue at day 3, 7 and 14 as compared to wildtype mice. Values are expressed as % area of the region of interest and as mean7SD; *po0.05.
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mained signiﬁcantly lower in NOX4-/- mice (po0.05). At day 14,
the dityrosine expression slightly decreased in both groups
(34.178.6% vs 13.576.7% of ROI stained for wildtype and NOX4-/-
respectively), the difference between the two groups being again
statistically signiﬁcant (po0.05) (see Fig. 4).
In the epithelium, dityrosine formation was generally stronger
as compared to the granulation tissue. At day 3, wildtype mice
showed 54.5720.5% and NOX4-/- mice 24.8713.4% of ROI
stained. At day 7, 48.4711.9% and 67.971.0% of the ROI was
stained and at day 14, 68.878.4% and 47.470.3% respectively for
wildtype and NOX4-/- mice. None of the results in the epithelium
were statistically different between wildtype and NOX4-/- mice.
3.5. NOX2 expression
NOX2 staining showed no difference between wildtype and
NOX4-/- mice at day 3 (2.270.6% and 1.770.2% of ROI stained
respectively). However, a signiﬁcantly weaker signal was seen at
day 7 in NOX4-/- mice (1.670.3% of ROI stained) compared to
wildtype mice (5.271.5% of ROI stained). At day 14, there was
again no signiﬁcant difference found between wildtype and
NOX4-/-, as NOX2 expression decreased in wildtype mice to
3.070.4% of ROI stained, being similar to NOX4-/- mice at this
time point (1.470.6% of ROI stained). Speciﬁcity of the NOX2
antibody was tested by staining cultured bone-marrow-derived
dendritic cells from either wildtype or NOX2-/- mice (see Fig. 5).
3.6. MPO expression
No signiﬁcant difference was found between NOX4-/- mice and
wild type mice when staining granulation tissues for MPO. The
signal was strongest at day 3 (5.674.6% in wildtype and 4.871.1%
of ROI stained in NOX4-/- mice) and gradually decreased. At day 7,
4.071.4% of ROI was stained in wildtype mice and 2.171.2% in
NOX4-/- mice. At day 14, it was 2.371.5% and 1.770.1%
respectively.0.1% of ROI was stained in our negative control (spinal cord
tissue of wildtype mice). 4.1% of ROI was stained in our positive
control (spinal cord from an amyotrophic lateral sclerosis mouse
model). Our isotype control showed no staining (see Fig. 6).3.7. Hypoxia inducible factor
HIF1α staining of the granulation tissue at day 3 showed
24.877.4% of ROI stained in the control group compared to
5.170.2 in the NOX4-/- group (po0.05). At day 14, expression
increased in both groups, but remained signiﬁcantly higher in the
control group (33.274.6%) as compared to the NOX4-/- group
(13.574.2% of ROI stained, po0.05). At day 14, expressionwas the
highest in both groups being 35.470.4% in the control group and
27.771.3% in the NOX4-/- group. The difference at day 14 was not
statistically signiﬁcant (see Fig. 7).
HIF1α expression was stronger in the epithelium at the wound
edge as compared to the granulation tissue. The highest expres-
sion was found at day 14 with 52.277.6% in the control group and
52.8710.9% in the NOX4-/- group. None of the results in the
epithelium were statistically different between the control and
NOX4-/- group.3.8. Neoangiogenesis and CD31 expression
CD31 staining was used to study wound angiogenesis. At day 3,
low levels of CD31 expression were found (2.171.3 wildtype vs
1.771.0 NOX4-/-). A strong increase was observed in control an-
imals at day 7, while this increase was less pronounced in NOX4-/-
mice (6.670.7% vs 3.370.4% respectively, po0.05). However,
CD31 expression strongly increased between day 7 and 14 in
NOX4-/- mice while control animals showed only a slight increase
in the same period. In fact, NOX4-/- wounds reached similar levels
of expression by day 14 as compared to the control group (7.77
0.5% control vs 6.37 0.8% NOX4-/-; ns) (see Fig. 8).
Fig. 5. NOX2 expression. Immunohistochemistry showing NOX2 expression at day 3, 7 and 14 after wound inﬂiction in wildtype (left column) and NOX4-/- mice (middle
column). E¼epithelium; G¼granulation tissue. NOX2 expression appeared weaker in the NOX4-/- group at day 7. Computer-assisted quantiﬁcation (right column) showed a
signiﬁcant impair of dityrosine expression in NOX4-/- mice in the granulation tissue at day 7 as compared to wildtype mice. Isotype control staining showed no signal (right
column, middle picture). NOX2 antibody control staining on cultured bone-marrow-derived dendritic cells from wildtype and NOX2-/- mice showed speciﬁc staining (right
lower corner). Values are expressed as % area of the region of interest and as mean7SD; *po0.05.
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Our study shows for the ﬁrst time that NOX4-deﬁciency leads
to signiﬁcantly impaired cutaneous wound repair. Wounds in both
wildtype and NOX4-deﬁcient mice healed predominatelyFig. 6. Myeloperoxidase. Immunohistochemistry showing myeloperoxidase presence at
(middle column). E¼epithelium; G¼granulation tissue, a¼ representative view of cell ac
3 and continuously decreased over time. Computer-assisted quantiﬁcation (right column
the granulation tissue at day 3, 7 and 14 as compared to wildtype mice. The negative co
was stained in positive control tissues (PCO). Isotype control staining was negative (rig(9372%) through wound contraction, suggesting that the delay in
healing associated with NOX4-deﬁciency in our model is mainly
due to impaired wound contraction. However, in our study NOX4
was not required for myoﬁbroblast differentiation during wound
contraction and αSMA expression patterns were very similarday 3, 7 and 14 after wound inﬂiction in wildtype (left column) and NOX4-/- mice
cumulations observed in both groups. Myeloperoxidase was detected as early as day
) showed no signiﬁcant difference in myeloperoxidase formation in NOX4-/- mice in
ntrol (NCO) showed a signal in 0.1% of the region of interest (ROI) while 4.1% of ROI
ht lower corner). Values are expressed as % area of ROI and as mean7SD.
Fig. 7. HIF1α expression. Immunohistochemistry showing HIF1α expression at day 3, 7 and 14 after wound inﬂiction in wildtype (left column) and NOX4-/- mice (middle
column). E¼epithelium; G¼granulation tissue. HIF1α expression appeared weaker in the NOX4-/- group at all time points in the granulation tissue. No difference was seen
in the epithelium at the wound edge. Computer-assisted quantiﬁcation (right column) showed a signiﬁcantly lower expression at day 3 and day 7 in the granulation tissue in
the NOX4-/- group compared the control group, no signiﬁcant difference was seen at day 14. Values are expressed as % area of the region of interest and as mean7SD;
*po0.05.
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other studies where NOX4 was shown to be a prerequisite for
myoﬁbroblast differentiation of cardiac [14] and pulmonary ﬁ-
broblasts [15]. Our results suggest that NOX4 is required for
myoﬁbroblast differentiation in a situation- and/or tissue-speciﬁc
manner.Fig. 8. CD31 expression. Immunohistochemistry showing CD31 expression at day 3, 7 a
column). E¼epithelium; G¼granulation tissue; S¼scab. Similar levels of CD31 express
control group which appeared weaker in the NOX4-/- group. Computer-assisted quan
granulation tissue in the NOX4-/- group compared the control group. At day 14, wounds
similar levels to the control group. Quantiﬁcation showed no signiﬁcant difference at day
and as mean7SD; *po0.05.The fact that wound contraction was signiﬁcantly impaired
despite seemingly unchanged myoﬁbroblast expression raises a
series of questions regarding the role of the myoﬁbroblast as the
main cell orchestrating wound contraction and regarding the exact
mechanisms that lead to the generation of contractile forces
within the wound bed.nd 14 after wound inﬂiction in wildtype (left column) and NOX4-/- mice (middle
ion were seen at day 3 in both groups. A strong increase was seen at day 7 in the
tiﬁcation (right column) showed a signiﬁcantly lower expression at day 7 in the
in NOX4-/- mice showed a strong increase of CD31 expression and had now reached
14 between the two groups. Values are expressed as % area of the region of interest
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impaired in NOX4-deﬁcient mice, we looked for possible ex-
planations why myoﬁbroblast contraction could be less effective
despite preserved αSMA expression. Fully differentiated myoﬁ-
broblasts show a strong expression of stress ﬁbers and ﬁbronectin
[1,39–41] and are traditionally associated with the expression of
αSMA [42]. The incorporation of αSMA into stress ﬁbers is be-
lieved to be the backbone of their contractile activity [43,44].
However, recent data suggests that αSMA expression is not a pre-
requisite for myoﬁbroblast contraction during wound repair and
that smooth muscle γ-actin and skeletal muscle α-actin can
completely compensate for a lack of αSMA [45,46]. Possibly, NOX4
plays a role in the expression of other muscle actins than αSMA,
such as smooth muscle γ-actin or skeletal muscle α-actin in
myoﬁbroblast function during wound repair. If this is the case,
NOX4-deﬁcient myoﬁbroblasts could be less contractile despite
expressing normal amounts of αSMA. Further (in vitro) studies
should investigate whether NOX4-deﬁcient skin-derived myoﬁ-
broblasts show a different pattern of actin expression.
The mechanical properties of the ECM are of primordial im-
portance to translate the cellular contraction of myoﬁbroblasts
into a contraction of the wound tissue. While the provisional
matrix of early granulation tissue is highly compliant, the mature
granulation tissue becomes increasingly stiff over time [47]. Mi-
grating ﬁbroblasts remodel the ECM, synthesizing a variety of ECM
components, such as collagen and ﬁbronectins [48,49]. It is cur-
rently thought that traction forces induced by ﬁbroblast migration
within the provisional matrix and their ECM-remodeling activity
gradually increase the stiffness of the granulation tissue [1,50–52].
NOX4 has been shown to be required for ECM component pro-
duction in lung-derived ﬁbroblasts in vitro [15,53]. Targeting NOX4
results in attenuation of an established ﬁbrotic response, with
reductions in gene transcripts for the extracellular matrix com-
ponents collagen 1α1, collagen 3α1, and ﬁbronectin [53]. Accord-
ingly, in this study we found that collagen deposition was sig-
niﬁcantly reduced in NOX4-deﬁcient mice. A less dense collagen
matrix could explain a lack of translation of the cellular forces into
a contraction of the tissue as a whole. However, a lack of rigidity
should also lead to a reduction in myoﬁbroblast expression, which
is not the case in our study.
In addition to the expression of ECM components, their cross-
linking is likely to play an important role in the transduction of
contractile forces [47,54,55]. This is a little understood process
where NOX enzymes are particularly likely to play a crucial role. As
outlined before, we hypothesized that NOX-mediated dityrosine
crosslinking of the ECM is a possible player in wound contraction.
In fact, dityrosine formation signiﬁcantly increased during the
wound repair process in our study, suggesting it has a physiolo-
gical role. To the best of our knowledge, this study provides the
ﬁrst data suggestive of a physiological function of dityrosine
crosslinking in mammals. We could also show that NOX4-deﬁ-
ciency leads to signiﬁcant impairment of dityrosine expression,
providing a possible explanation as to how myoﬁbroblast con-
traction in NOX4-deﬁcient mice might be less effective in con-
tracting the wound. It is conceivable that myoﬁbroblast contrac-
tion is only effectively translated into tissue contraction if cells are
imbedded in a well cross-linked ECM [56–58].
Tyrosine dimerization is thought to require the presence of ROS
(i.e. H2O2) and of a peroxidase [24,59]. In fact, there is strong
evidence that peroxidases mediate ECM crosslinking [25,60]. One
possible source of peroxidase during physiological wound repair is
macrophages and neutrophils as they are known to secrete mye-
loperoxidase (MPO), which is mainly known for its role in host
defense. However, in our study we observe no correlation between
dityrosine formation and MPO expression. Also, there was no
difference in expression between wildtype and NOX4-/- mice,suggesting that MPO is not the main peroxidase catalyzing dityr-
osine formation during wound repair.
A promising candidate for a major role in mediating ECM
crosslinking is vascular peroxidase 1 (VPO1, a.k.a. peroxidasin,
PXDN) as it contains, besides its peroxidase domain, modules that
are characteristic of the ECM [61]. VPO1 has also been shown to be
secreted by myoﬁbroblasts into the ECM, where it organizes into a
ﬁbril-like network colocalizing with ﬁbronectin [62]. In fact, Lázár
et al. have found that VPO1 mediates the crosslinking of collagen
IV in hot spots near the cell surface [63]. It has also been suggested
that VPO1 catalyzes tyrosyl radical formation and promotes di-
tyrosine cross-linking [64]. VPO1 requires H2O2 to function, which
is supplied to the enzyme by a currently unknown cellular source.
In a model of hypoxia-induced pulmonary hypertension, Liu et al
propose NOX4 as a provider of hydrogen peroxidase for VPO1
during inﬂammatory reaction [65] but to our knowledge the re-
lation between NOX4 and VPO1 is yet to be established. We think
NOX4 is a promising candidate as a provider of H2O2 for VPO1-
mediated collagen crosslinking through tyrosine dimerization,
which could be an important mechanism of granulation tissue
stiffening during skin wound repair.
Besides tyrosine formation, peroxidases also catalyze other
protein cross-links, which might also participate along with di-
tyrosine to the stiffening of the ECM. For instance, peroxidase-
catalyzed cross-link is formed from the deamination of protein
lysyl ϵ-amino groups to form lysyl aldehydes, which then react
with amino acid residues of adjacent molecules [66,67].
In order to understand whether NOX4 is directly involved in
the dityrosine cross-linking reaction or whether the presence of
dityrosine in the wound could also be explained by a NOX4-de-
pendent recruitment and/or activation of phagocytic cells, we
looked at NOX2 expression in the granulation tissue. We found a
signiﬁcantly weaker expression of NOX2 at day 7 in the wounds of
NOX4-/- mice, suggesting that NOX4 plays a role in the recruit-
ment of phagocytic cells into the wound. This recruitment could
take place through NOX4 dependent interleukin-6 (IL-6) expres-
sion, similar to what has been shown in human microglia and non-
small cell lung cancer cells [56,57]. IL-6 plays an essential role in
skin wound repair as evidenced by delayed wound healing in IL-6-
deﬁcient mice [58]. These results suggest that NOX4 deﬁciency
leads to a reduction of dityrosine formation at least partly through
a reduction in NOX2-induced ROS in the granulation tissue. NOX2
has also been associated with VPO1 expression before and it is
possible that NOX2 provides ROS for VPO1-mediated dityrosine
formation [65,68].
As discussed above, HIF1α has been repeatedly associated with
NOX4 [53]. In this study we show that NOX4-deﬁciency is in fact
linked to a signiﬁcant delay in HIF1α expression in the granulation
tissue. However, it appears that other pathways can compensate
for the lack of NOX4 as expression was ﬁrst delayed in the
knockout group but eventually reached levels similar to the con-
trol group at day 14. Accordingly, we found that angiogenesis as
visualized by CD31 staining was delayed in NOX4-deﬁcient mice
with a signiﬁcantly lower expression at day 7 that eventually
reached similar levels to control at day 14. This is in line with
earlier studies that showed that NOX4 is required for effective
angiogenesis [28]. NOX4 has also been extensively studied for its
role as an oxygen sensor and it has been demonstrated that NOX4
is capable of generating hydrogen peroxide as a function of oxygen
concentration throughout a physiological range of pO2 values and
to respond rapidly to changes in pO₂ [69].
In an earlier study investigating αSMA expression on wrinkling
substrates over time we showed that hypoxia reduced myoﬁbro-
blast contraction from approximately 70 to 15% [70]. It is con-
ceivable that a decrease of HIF1α leads to a reduction in wound
vascularization and thus oxygenation, triggering the loss of
D. Lévigne et al. / Free Radical Biology and Medicine 96 (2016) 374–384382contractility of myoﬁbroblasts. However, we had also shown that a
persistent state of ischemia signiﬁcantly reduces αSMA expression
in the wound bed, which was not the case in the current study.
In vitro, the loss in contractility clearly preceded the loss in αSMA
expression [70]. Possibly, a light decrease in wound oxygenation –
as opposed to severe ischemia – leads to a loss of contractility but
not to a loss of αSMA expression in myoﬁbroblasts. Further studies
should investigate the effects of hypoxia on the expression of ac-
tins other than αSMA in myoﬁbroblasts.
Besides wound contraction, re-epithelialization is an important
process for effective wound closure. In this study we did not detect
any difference in re-epithelialization but it is possible that NOX4
also interferes with keratinocyte activity during re-epithelializa-
tion as recent data suggests that keratinocytes are producing ROS
via NOX enzymes, including NOX4 [71,72]. It has been shown that
ROS at low concentrations induce keratinocyte migration in vitro
[73,74]. Matrix metalloproteinase (MMP) production is essential
for keratinocyte migration as it contributes to cleaving a path
through the ECM [75,76]. The collagenase MMP-1 is an important
constituent of the matrix-degrading apparatus of keratinocytes
and is expressed in a NOX4-mediated, ROS-dependent way [77].
The isoform NOX1 has been studied in epithelial repair of in-
testinal mucosa healing and it has been reported that NOX1
mediates epithelial migration through activation and modiﬁcation
of focal adhesion proteins involved in regulating cell migration
[78]. Our analyses of the wound do not indicate any major im-
pairment of re-epithelialization in NOX4-deﬁcient mice but the
wound model used in this study does not seem appropriate to
study re-epithelialization as wounds heal overwhelmingly
through contraction. More speciﬁc analysis should be done in or-
der to better understand the repercussions of NOX4 deﬁciency on
re-epithelialization during wound repair, possibly by using a
splintered wound model.5. Conclusions
In this study we show for the ﬁrst time that NOX4 plays a role
in cutaneous wound repair. We provide evidence that NOX4 pro-
motes dityrosine crosslinking of the ECM as well as the recruit-
ment of phagocytic cells, as signiﬁcantly less NOX2-positive cells
were detected in NOX4-/-mice. NOX4-deﬁciency also led to re-
duced HIF1α and CD31 expression, suggesting a role of NOX4 in
neoangiogenesis during wound repair. NOX4 was required for ef-
fective wound contraction but – surprisingly – not for myoﬁbro-
blast expression, challenging the role of the myoﬁbroblast as the
primordial mediator of wound contraction. We suggest that
myoﬁbroblast contraction in NOX4-deﬁcient mice is less effective
in contracting the wound because of insufﬁcient dityrosine
crosslinking of the ECM. MPO expression was not signiﬁcantly
altered by NOX4 deletion, suggesting that other peroxidases are
involved in dityrosine formation during wound repair, possibly
VPO1. In fact, this study allows us to propose the ﬁrst physiological
role of dityrosine crosslinking in higher animals, as we observed a
strong upregulation in wildtype mice during skin wound repair.Author declaration
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